Vaccitech – Mary Lou MacDonald TD

Bernie MacDonald is a Director of Vaccitech.  Bernie is also a sibling to Mary Lou MacDonald, Leader of the Sinn Fein political party in opposition in Ireland’s Dail Eireann.  Conflict of interest for Mary Lou?  You decided.

Vaccitech Team

The company’s proprietary heterologous prime-boost platform comprises Chimpanzee Adenovirus Oxford (ChAdOx) and Modified Vaccinia Ankara (MVA), two non-replicating viral vectors which safely mimic viral infection in human cells and elicit high magnitude, durable, targeted CD8+ and CD4+ T cell responses and antibodies to clear foreign pathogens and tumours.

Vaccitech is backed by leading investment institutions, including M&G, Tencent, Gilead Sciences, GV (formerly Google Ventures), Sequoia Capital China, Liontrust (formerly Neptune), Korea Investment Partners and Oxford Sciences Innovation.

Vaccitech: Spin out kick starts with £10m from Oxford Sciences Innovation

The Brilliant but Widely Loathed Scientist Behind the AstraZeneca Vaccine – 20 Nov 2021

Oxford Developed Covid Vaccine, Then Scholars Clashed Over Money – 21 Oct 2021

UK Covid booster not necessary for all, says Oxford jab scientist Sarah Gilbert – 10 Sept 2021

Coronavirus could be with us for many years, says vaccine creator -5 July 2021

Vaccitech chief confident of beating mRNA in cancer treatment 21 June 2021

Team Oxford: The seven celebrated scientists who took on Covid-19Sarah Gilbert, Andrew Pollard, Peter Horby (professor of emerging infectious diseases and global health at Oxford University, was there from the beginning, remotely involved in drug trials in Wuhan, China, in January 2020 – the epicentre of the global outbreak.), Martin Landray, Catherine Green, Teresa Lambe and Adrian Hill11 June 2021

Vaccitech Announces Pricing of Initial Public Offering – 29 April 2021

Biotech behind AstraZeneca vaccine aims to raise $117m at IPO 26 April 2021

Irish scientist Adrian Hll heads team behind malaria vaccine hailed as breakthrough – 23 April 2021

AstraZeneca vaccine scientists set for £22m payday in New York float – Prof Sarah Gilbert, the scientist who led the team that created the Oxford/AstraZeneca coronavirus vaccine, is set for a payday of more than £20m as the biotech firm she co-founded prepares to float on the stock market in the US. – Adrian Hill also owns a 5.2% stake, according to filings at Companies House. If the company achieved a flotation value of £425m, Gilbert’s and his stakes would be worth £22m each. Oxford University could also collect a big windfall, as it holds a 5.4% stake directly. It also owns further stakes through the university’s spin-out holding company, Oxford Sciences Innovation (OSI).7 April 2021

Vaccitech: Oxford vaccine pioneers in line for payout worth millions

AstraZeneca, once touted as a pandemic slayer, faces challenges – 22 March 2021

Vaccitech Completes $168 Million Series B Financing to Advance Three Clinical Programs Through Phase 2 Results – 17 March 2021

AstraZeneca Company Tied to UK Eugenics Movement

  • mainstream media has had little, if anything, to say about the role of the vaccine developers’ private company—Vaccitech—in the Oxford-AstraZeneca partnership, a company whose main investors include former top Deutsche Bank executives, Silicon Valley behemoth Google, and the UK government. All of them stand to profit from the vaccine alongside the vaccine’s two developers, Adrian Hill and Sarah Gilbert, who retain an estimated 10 percent stake in the company. 2 March 2021
  • Most troubling of all is the direct link of the vaccine’s lead developers to the Wellcome Trust and, in the case of Adrian Hill, the Galton Institute, two groups with longstanding ties to the UK eugenics movement.
  • The ties of Adrian Hill to the Galton Institute should raise obvious concerns given the push to make the Oxford-AstraZeneca vaccine he developed with Gilbert the vaccine of choice for the developing world, particularly countries in Latin America, South and Southeast Asia, and Africa, the very areas where the Galton Institute’s past members have called for reducing population growth.

Prof Sarah Gilbert: The woman who designed the Oxford vaccine – 23 Nov 2020

Sarah Gilbert

Vaccitech receives government grant for COVID-19 vaccine researchVaccitech was awarded £155k for the first phase of the project worth up to £2.3m in funding.  – 27 Aug 2020

Vaccitech Secures £20M in Series A Funding Led by Tom Evans, Chief Executive Officer, Vaccitech is commercializing the research of vaccine development specialists Adrian Hill and Sarah Gilbert, who developed the underpinning technology at Oxford University’s Jenner Institute –15 Jan 2018

Adrian Hill –  – 8 Aug 2013

Are you thinking something is not quite right?